Alzheimer's & dementia : the journal of the Alzheimer's Association
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Early life exposure to structural sexism and late-life memory trajectories among black and white women and men in the United States.
2024
-
Pathways to personalized medicine-Embracing heterogeneity for progress in clinical therapeutics research in Alzheimer's disease..
20:7384-7394.
2024
-
Loneliness, cerebrovascular and Alzheimer's disease pathology, and cognition..
20:7113-7123.
2024
-
Subjective cognitive decline and cognitive change among diverse middle-aged and older Hispanic/Latino adults: Results from the Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA)..
20:7715-7728.
2024
-
Increasing research study engagement in minoritized populations: An example from the Black Women Inflammation and Tau Study..
20:7403-7410.
2024
-
Correlates of missed or late versus timely diagnosis of dementia in healthcare settings..
20:5551-5560.
2024
-
Neighborhood racial income inequality and cognitive health..
20:5338-5346.
2024
-
Concurrent nutrient deficiencies are associated with dementia incidence..
20:4594-4601.
2024
-
Bridging the Gap: Multi-Omics Profiling of Brain Tissue in Alzheimer's Disease and Older Controls in Multi-Ethnic Populations..
20:7174-7192.
2024
-
Histories of neighborhood socioeconomic status contribute to race differences in later-life cognition..
20:3342-3351.
2024
-
Promoting diverse perspectives: Addressing health disparities related to Alzheimer's and all dementias..
20:3099-3107.
2024
-
Analysis of agreement between measures of subjective cognitive impairment and probable dementia in the National Health and Aging Trends Study..
20:2817-2829.
2024
-
Whole genome-wide sequence analysis of long-lived families (Long-Life Family Study) identifies MTUS2 gene associated with late-onset Alzheimer's disease..
20:2670-2679.
2024
-
General cognitive ability in high school, attained education, occupational complexity, and dementia risk..
20:2662-2669.
2024
-
Lewy body dementia: Overcoming barriers and identifying solutions..
20:2298-2308.
2024
-
Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer's disease and related dementias..
20:2089-2101.
2024
-
Plasma biomarkers of Alzheimer's disease and related dementias in American Indians: The Strong Heart Study..
20:2072-2079.
2024
-
Risk of Alzheimer's disease is associated with longitudinal changes in plasma biomarkers in the multi-ethnic Washington Heights-Hamilton Heights-Inwood Columbia Aging Project (WHICAP) cohort..
20:1988-1999.
2024
-
A novel neuroimaging signature for ADRD risk stratification in the community..
20:1881-1893.
2023
-
Spouses of individuals living with mild cognitive impairment or dementia in the United States: A descriptive, population-based study..
20:1562-1572.
2023
-
How reactions to a brain scan result differ for adults based on self-identified Black and White race..
20:1527-1537.
2023
-
Psychosocial factors associated with 7-year change in cognition among middle-aged and older Hispanics/Latinos: The Hispanic Community Health Study/Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA) and Sociocultural ancillary studies..
20:1137-1148.
2023
-
Maximizing utility of neuropsychological measures in sex-specific predictive models of incident Alzheimer's disease in the Framingham Heart Study..
20:1112-1122.
2023
-
Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS)..
19 Suppl 9:S98-S114.
2023
-
Sex differences in the association between tau PET and cognitive performance in a non-Hispanic White cohort with preclinical AD..
20:25-33.
2023
-
Does education moderate gender disparities in later-life memory function? A cross-national comparison of harmonized cognitive assessment protocols in the United States and India..
20:16-24.
2023
-
Distinct transcriptomic responses to Aβ plaques, neurofibrillary tangles, and APOE in Alzheimer's disease..
20:74-90.
2023
-
White matter hyperintensities and Alzheimer's disease: An alternative view of an alternative hypothesis..
19:4260-4261.
2023
-
Long-term blood pressure patterns in midlife and dementia in later life: Findings from the Framingham Heart Study..
19:4357-4366.
2023
-
Serum NfL and GFAP are associated with incident dementia and dementia mortality in older adults: The cardiovascular health study..
19:5672-5680.
2023
-
Demographically-adjusted normative data among Latinos for the version 3 of the Alzheimer's Disease Centers' Neuropsychological Test Battery in the Uniform Data Set..
19:4174-4186.
2023
-
Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease..
19:4127-4138.
2023
-
Global rural health disparities in Alzheimer's disease and related dementias: State of the science..
19:4204-4225.
2023
-
Expanding the use of brief cognitive assessments to detect suspected early-stage cognitive impairment in primary care..
19:4252-4259.
2023
-
The structural and social determinants of Alzheimer's disease related dementias..
19:3171-3185.
2023
-
Sex differences in associations between APOE ε2 and longitudinal cognitive decline..
19:4651-4661.
2023
-
Re-remembering the influence of randomized β-carotene on cognitive decline..
19:3718-3721.
2023
-
The Nairobi Declaration-Reducing the burden of dementia in low- and middle-income countries (LMICs): Declaration of the 2022 Symposium on Dementia and Brain Aging in LMICs.
2023
-
Placental growth factor as a sensitive biomarker for vascular cognitive impairment..
19:3519-3527.
2023
-
Obesity impacts the expression of Alzheimer's disease-related genes: The Framingham Heart Study..
19:3496-3505.
2023
-
Prevalence of dementia in India: National and state estimates from a nationwide study..
19:2898-2912.
2023
-
Amyloid‐, tau‐, and FDG‐PET in amyloid‐negative patients clinically diagnosed with early‐onset Alzheimer’s disease in the LEADS study
2023
-
Amyloid‐PET, tau‐PET, and their association in sporadic early‐onset Alzheimer’s Disease: Cross‐sectional and longitudinal data from the LEADS study
2023
-
Comparison of Expert Reads vs. Local Clinical Reads of Amyloid PET Scans in IDEAS
2023
-
Perceptions about Dementia Clinical Trials
2023
-
Quantitative Amyloid‐PET in Real‐World Practice: Lessons from the Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) study
2023
-
Regional patterns of pathological tau accumulation in sporadic early‐onset Alzheimer’s disease: Longitudinal tau‐PET in the LEADS Cohort
2023
-
Towards the future of ADRD diagnosis: combination of a brief digital cognitive battery and plasma biomarkers for diagnosis and prognosis of disease
2023
-
AD and non-AD mediators of the pathway between the APOE genotype and cognition..
19:2508-2519.
2022
-
Pulse pressure trajectories predict brain microstructure in community-dwelling older adults: Associations with executive function and modification by APOE..
19:1963-1973.
2022
-
The use of subjective cognitive complaints for detecting mild cognitive impairment in older adults across cultural and linguistic groups: A comparison of the Cognitive Function Instrument to the Montreal Cognitive Assessment..
19:1764-1774.
2022
-
Digital culturally tailored marketing for enrolling Latino participants in a web-based registry: Baseline metrics from the Brain Health Registry..
19:1714-1728.
2022
-
Biomarkers for dementia in Latin American countries: Gaps and opportunities..
19:721-735.
2022
-
To donate, or not to donate, that is the question: Latino insights into brain donation..
19:1274-1280.
2022
-
Higher Dietary Inflammatory Index scores are associated with brain MRI markers of brain aging: Results from the Framingham Heart Study Offspring cohort..
19:621-631.
2022
-
Consideration of sex and gender in Alzheimer's disease and related disorders from a global perspective..
18:2707-2724.
2022
-
Waning locus coeruleus integrity precedes cortical tau accrual in preclinical autosomal dominant Alzheimer's disease..
19:169-180.
2022
-
Addressing the disparities in dementia risk, early detection and care in Latino populations: Highlights from the second Latinos & Alzheimer's Symposium..
18:1677-1686.
2022
-
Is there a difference between terminal lucidity and paradoxical lucidity?.
18:540-541.
2022
-
Traumatic brain injury and dementia risk in male veteran older twins-Controlling for genetic and early life non-genetic factors..
18:2234-2242.
2022
-
Primary prevention recommendations to reduce the risk of cognitive decline..
18:1569-1579.
2022
-
18F‐MK‐6240 Tau PET as a Biomarker for Chronic Traumatic Encephalopathy: Case Series of 10 Symptomatic Former National Football League Players
2022
-
Amyloid Negative, Highly Tau Positive: Clinical Characterization of a Rare Biomarker Profile
2022
-
Quantitative analysis of 6,150 real‐world amyloid Positron Emission Tomography (PET) scans from the Imaging Dementia–Evidence for Amyloid Scanning (IDEAS) study
2022
-
Plasma p-tau181 shows stronger network association to Alzheimer''s disease dementia than neurofilament light and total tau..
18:1523-1536.
2021
-
ARMADA: Assessing reliable measurement in Alzheimer's disease and cognitive aging project methods..
18:1449-1460.
2021
-
Current directions in tau research: Highlights from Tau 2020..
18:988-1007.
2021
-
What is paradoxical lucidity? The answer begins with its definition..
18:513-521.
2021
-
Subjective cognitive decline and objective cognition among diverse U.S. Hispanics/Latinos: Results from the Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA)..
18:43-52.
2021
-
Social network characteristics moderate associations between cortical thickness and cognitive functioning in older adults..
18:339-347.
2021
-
Association of Life's Simple 7 with incident dementia and its modification by the apolipoprotein E genotype..
17:1905-1913.
2021
-
Systematic in silico analysis of clinically tested drugs for reducing amyloid-beta plaque accumulation in Alzheimer's disease..
17:1487-1498.
2021
-
Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study..
17:1353-1364.
2021
-
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols..
17:704-715.
2021
-
MarkVCID cerebral small vessel consortium: II. Neuroimaging protocols..
17:716-725.
2021
-
Comparison of plasma and CSF biomarkers across ethnoracial groups in ADNI
2021
-
Higher dietary inflammatory index scores are associated with increased incidence of all‐cause dementia in the Framingham Heart Study
2021
-
IDEAS and New IDEAS: Amyloid PET in diverse populations
2021
-
APOE alleles' association with cognitive function differs across Hispanic/Latino groups and genetic ancestry in the study of Latinos-investigation of neurocognitive aging (HCHS/SOL)..
17:466-474.
2020
-
Self-reported obstructive sleep apnea, amyloid and tau burden, and Alzheimer's disease time-dependent progression.
2020
-
Education differentially contributes to cognitive reserve across racial/ethnic groups..
17:70-80.
2020
-
Dietary fatty acids and risk of Alzheimer's disease and related dementias: Observations from the Washington Heights-Hamilton Heights-Inwood Columbia Aging Project (WHICAP)..
16:1638-1649.
2020
-
Racially diverse participant registries to facilitate the recruitment of African Americans into presymptomatic Alzheimer's disease studies..
16:1107-1114.
2020
-
Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer's disease..
16:681-695.
2020
-
Perspective on the “African American participation in Alzheimer disease research: Effective strategies” workshop, 2018
2020
-
Plasma YKL40 as a biomarker for brain aging and injury in three community cohorts
2020
-
Novel methods for integration and visualization of genomics and genetics data in Alzheimer's disease..
15:788-798.
2019
-
P2-510: TOWARDS A NOVEL INTERVENTION FOR BLACK FAMILY CAREGIVERS OF PERSONS WITH DEMENTIA
2019
-
Vascular dysfunction-The disregarded partner of Alzheimer's disease..
15:158-167.
2019
-
Progress and future challenges in aging and diversity research in the United States..
15:995-1003.
2018
-
What features of stigma do the public most commonly attribute to Alzheimer's disease dementia? Results of a survey of the U.S. general public..
14:925-932.
2018
-
Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohorts..
14:723-733.
2018
-
Sleep characteristics and risk of dementia and Alzheimer's disease: The Atherosclerosis Risk in Communities Study..
14:157-166.
2017
-
Post-traumatic stress disorder and risk of dementia among members of a health care delivery system..
14:28-34.
2017
-
Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study..
13:1327-1336.
2017
-
Sugary beverage intake and preclinical Alzheimer's disease in the community..
13:955-964.
2017
-
Transethnic genome-wide scan identifies novel Alzheimer's disease loci..
13:727-738.
2017
-
Effects of cognition, function, and behavioral and psychological symptoms on out-of-pocket medical and nursing home expenditures and time spent caregiving for persons with dementia..
13:801-809.
2017
-
[O3–05–06]: REM SLEEP MECHANISMS PREDICT INCIDENT DEMENTIA IN THE FRAMINGHAM HEART STUDY
2017
-
Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation..
13:267-273.
2016
-
Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans..
13:119-129.
2016
-
Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort..
13:399-405.
2016
-
METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research..
12:1235-1249.
2016
-
Amyloid-beta oligomerization is associated with the generation of a typical peptide fragment fingerprint..
12:996-1013.
2016
-
Endogenous sex hormones and cognitive function in older women..
12:758-65.
2016
-
Interarm differences in systolic blood pressure and the risk of dementia and subclinical brain injury..
12:438-45.
2015
-
Massachusetts Alzheimer's Disease Research Center: progress and challenges..
11:1241-5.
2015
-
Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk..
12:233-43.
2015
-
Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage..
11:1480-1488.
2015
-
APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role?.
10:619-29.
2014
-
Subjective cognitive concerns, episodic memory, and the APOE ε4 allele..
10:752-759.e1.
2014
-
Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study..
11:249-57.e1.
2014
-
Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans..
10:609-618.e11.
2014
-
At the interface of sensory and motor dysfunctions and Alzheimer's disease..
11:70-98.
2014
-
Development and validation of a brief dementia screening indicator for primary care..
10:656-665.e1.
2014
-
Gender and incidence of dementia in the Framingham Heart Study from mid-adult life..
11:310-320.
2014
-
The Kitchen Picture Test (KPT): A new test of practical judgment
2013
-
Magnetic resonance imaging-measured atrophy and its relationship to cognitive functioning in vascular dementia and Alzheimer's disease patients..
7:493-500.
2011
-
Assessment of cognition in early dementia..
7:e60-e76.
2011
-
Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 2..
7:35-52.
2011
-
O2‐05‐02: IMPACT OF AGE ON THE ASSOCIATION BETWEEN VASCULAR RISK FACTOR BURDEN AND BRAIN VOLUME
2006
-
Childhood head injury, control beliefs, and later life cognitive function in the Health and Retirement Study
2020
-
Lifetime stressful experiences and cognitive performance in African American and white older adults: New evidence from a population‐based cohort
2020
-
Little progress in reducing relative racial disparities in the incidence and prevalence of dementia in the United States, 2000‐2016
2020
Identity
International Standard Serial Number (ISSN)